FDA Approved Products

1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: PeakClear all
KYZATREX
testosterone undecanoate
Peak
Marius Pharmaceuticals
ORAL · CAPSULE
2022
NDA
0/100
LANSOPRAZOLE
lansoprazole
Peak
Bridge Therapeutics
ORAL · TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
2016
SMNDA
0/100
LATUDA
lurasidone hydrochloride
Peak
ORAL · TABLET
schizophreniadepression
2010
NDA
0/100
LAZANDA
fentanyl citrate
Peak
NASAL · SPRAY, METERED
2011
NDA
0/100
LENVIMA
lenvatinib
Peak
Eisai
ORAL · CAPSULE
2015
SMNDA
0/100
LEQVIO
inclisiran
Peak
Novartis
SUBCUTANEOUS · SOLUTION
2021
RNANDA
0/100
LETAIRIS
ambrisentan
Peak
Gilead Sciences
ORAL · TABLET
2007
NDA
0/100
LEVOLET
levothyroxine sodium
Peak
ORAL · TABLET
2003
NDA
0/100
LEVOTHYROXINE SODIUM
levothyroxine sodium
Peak
Fresenius Kabi
INTRAVENOUS · SOLUTION
2019
NDA
0/100
LEVOTHYROXINE SODIUM
levothyroxine sodium
Peak
Hikma
INTRAVENOUS · SOLUTION
myxedema coma
2021
NDA
0/100
LEVOTHYROXINE SODIUM
levothyroxine sodium anhydrous
Peak
Fresenius Kabi
INTRAVENOUS · POWDER
myxedema coma
2011
NDA
0/100
LEVULAN
aminolevulinic acid hydrochloride
Peak
PharmaIN
TOPICAL · SOLUTION
minimally to moderately thick actinic keratoses of the facescalp+1
1999
NDA
0/100
LEXETTE
halobetasol propionate
Peak
TOPICAL · AEROSOL, FOAM
2018
NDA
0/100
LICART
diclofenac epolamine
Peak
IBSA Institut Biochimique
TOPICAL · SYSTEM
2018
NDA
0/100
LILETTA
levonorgestrel
Peak
Blueprint Medicines
INTRAUTERINE · SYSTEM
pregnancy for up to 8 yearsheavy menstrual bleeding for up to 5 years in patients
2015
NDA
0/100
LINZESS
linaclotide
Peak
AbbVie
ORAL · CAPSULE
2012
PeptideNDA
0/100
LIVMARLI
maralixibat chloride
Peak
Mirum Pharmaceuticals
ORAL · SOLUTION
cholestatic pruritus in patients 3 months of ageolder with Alagille syndrome (ALGS)+2
2021
NDA
0/100
LIVTENCITY
maribavir
Peak
Takeda
ORAL · TABLET
2021
SMNDA
0/100
LOCAMETZ
kit for the preparation of gallium ga 68 gozetotide
Peak
Novartis
INTRAVENOUS · POWDER
prostate cancer
2022
PeptideNDA
0/100
LOKELMA
sodium zirconium cyclosilicate
Peak
AstraZeneca
ORAL · FOR SUSPENSION
hyperkalemia in adults
2018
NDA
0/100
LONHALA MAGNAIR KIT
glycopyrrolate
Peak
Sumitomo Dainippon Pharma
INHALATION · SOLUTION
2017
NDA
0/100
LONSURF
trifluridine and tipiracil
Peak
Taiho Oncology
ORAL · TABLET
2015
NDA
0/100
LORBRENA
lorlatinib
Peak
Pfizer
ORAL · TABLET
2018
SMNDA
0/100
LOREEV XR
lorazepam
Peak
Almatica Pharma
ORAL · CAPSULE, EXTENDED RELEASE
anxiety disorders in adultsevenly divided+2
2021
NDA
0/100
← PreviousPage 38 of 55Next →